Outlook Therapeutics, Inc.
Biotechnology company · Iselin, New Jersey, United States · Nasdaq: OTLK
Outlook Therapeutics, Inc. is a biotechnology company headquartered in Iselin, New Jersey, United States. Its shares trade on Nasdaq under the ticker OTLK. It has reported private securities offerings to the US SEC, most recently $5 million sold in a notice filed in 2024.
Outlook Therapeutics at a glance
What does Outlook Therapeutics do?
Private fundraising reported to the SEC
8 Form D notices; the most recent reported $5 million sold (2024).
Frequently asked questions about Outlook Therapeutics
Where is Outlook Therapeutics headquartered?
Outlook Therapeutics, Inc. is headquartered in Iselin, New Jersey, United States.
What does Outlook Therapeutics do?
Outlook Therapeutics, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Is Outlook Therapeutics a public company?
Yes. Outlook Therapeutics, Inc. trades on Nasdaq under the ticker OTLK.
Similar companies
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
- Vaxcyte, Inc.San Carlos, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.